Oyster Point Pharma Inc
OYST
Get informed when a big investor buys or sells
+ FollowMarket Cap$0
Close$
$18.60
66.5% upside
Current Fair Value
66.5% upsideUndervalued by 66.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $0.00 |
|---|---|
| Enterprise Value | $25.92 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-4.01 |
| Beta | 0 |
| Outstanding Shares | 26,830,756 |
Return
| Return on Equity | 851.15% |
|---|---|
| Return on Assets | -173.05% |
| Return on Invested Capital | -205.39% |
Valuation & Multiples
| P/E Ratio | -2.79 |
|---|---|
| PEG | -2.18 |
| Price to Sales | - |
| Price to Book Ratio | -11.17 |
| Enterprise Value to Revenue | 1.32 |
| Enterprise Value to EBIT | -0.16 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 3.65 |
| Debt to Equity | -4.27 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data